Sundaravadivel Balasubramanian
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 8 | 2015 | 1204 | 1.040 |
Why?
|
| Myocytes, Cardiac | 10 | 2016 | 442 | 0.960 |
Why?
|
| Integrin beta3 | 5 | 2012 | 35 | 0.890 |
Why?
|
| Yoga | 2 | 2016 | 18 | 0.690 |
Why?
|
| Pressure | 4 | 2015 | 252 | 0.660 |
Why?
|
| Cardiomegaly | 6 | 2012 | 213 | 0.640 |
Why?
|
| Aorta | 2 | 2015 | 316 | 0.580 |
Why?
|
| Breathing Exercises | 1 | 2016 | 8 | 0.580 |
Why?
|
| Saliva | 2 | 2016 | 142 | 0.560 |
Why?
|
| Meditation | 1 | 2016 | 33 | 0.560 |
Why?
|
| Dasatinib | 1 | 2015 | 17 | 0.550 |
Why?
|
| Biomarkers | 2 | 2016 | 1593 | 0.470 |
Why?
|
| Extracellular Matrix | 2 | 2015 | 493 | 0.450 |
Why?
|
| Fibroblasts | 2 | 2015 | 902 | 0.400 |
Why?
|
| RANK Ligand | 3 | 2016 | 73 | 0.390 |
Why?
|
| Heart | 1 | 2015 | 850 | 0.380 |
Why?
|
| Ventricular Pressure | 2 | 2010 | 82 | 0.370 |
Why?
|
| Inflammation | 1 | 2016 | 1030 | 0.360 |
Why?
|
| Protein Isoforms | 1 | 2010 | 246 | 0.350 |
Why?
|
| Cats | 9 | 2016 | 292 | 0.350 |
Why?
|
| Actins | 1 | 2010 | 249 | 0.340 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2016 | 118 | 0.340 |
Why?
|
| Protein Kinases | 1 | 2009 | 122 | 0.320 |
Why?
|
| Cells, Cultured | 10 | 2017 | 2673 | 0.310 |
Why?
|
| Cell Proliferation | 5 | 2015 | 1173 | 0.280 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 89 | 0.280 |
Why?
|
| Ubiquitin | 1 | 2006 | 74 | 0.270 |
Why?
|
| Cytoskeletal Proteins | 1 | 2006 | 108 | 0.270 |
Why?
|
| Osteoclasts | 2 | 2017 | 132 | 0.270 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2016 | 65 | 0.260 |
Why?
|
| Apoptosis | 6 | 2013 | 1640 | 0.260 |
Why?
|
| Oligopeptides | 3 | 2009 | 152 | 0.250 |
Why?
|
| Focal Adhesion Kinase 2 | 2 | 2015 | 18 | 0.250 |
Why?
|
| Animals | 18 | 2017 | 20877 | 0.240 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2003 | 16 | 0.240 |
Why?
|
| Blotting, Western | 4 | 2017 | 954 | 0.220 |
Why?
|
| Mouth Neoplasms | 2 | 2016 | 206 | 0.210 |
Why?
|
| Heart Ventricles | 1 | 2006 | 738 | 0.210 |
Why?
|
| Calpain | 4 | 2011 | 205 | 0.200 |
Why?
|
| Cell Movement | 2 | 2015 | 630 | 0.200 |
Why?
|
| Hypertrophy | 5 | 2012 | 89 | 0.190 |
Why?
|
| Mice | 9 | 2017 | 8472 | 0.190 |
Why?
|
| Dipeptides | 3 | 2010 | 89 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 331 | 0.180 |
Why?
|
| Ubiquitination | 2 | 2011 | 85 | 0.180 |
Why?
|
| Caspase 3 | 4 | 2013 | 233 | 0.180 |
Why?
|
| Ventricular Function, Left | 2 | 2015 | 481 | 0.180 |
Why?
|
| Sirolimus | 2 | 2011 | 118 | 0.170 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1174 | 0.170 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2009 | 73 | 0.170 |
Why?
|
| Enzyme Activation | 3 | 2015 | 791 | 0.160 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 226 | 0.150 |
Why?
|
| Osteitis Deformans | 1 | 2017 | 19 | 0.150 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2010 | 117 | 0.150 |
Why?
|
| Weightlessness | 1 | 2016 | 25 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2015 | 305 | 0.140 |
Why?
|
| Constriction | 1 | 2015 | 37 | 0.140 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 20 | 0.140 |
Why?
|
| Hearing Loss, Central | 1 | 2015 | 9 | 0.140 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 55 | 0.140 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 76 | 0.140 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 32 | 0.130 |
Why?
|
| STAT6 Transcription Factor | 1 | 2014 | 11 | 0.130 |
Why?
|
| Neuroglia | 1 | 2015 | 136 | 0.130 |
Why?
|
| Cochlear Nerve | 1 | 2015 | 83 | 0.130 |
Why?
|
| Nerve Growth Factor | 1 | 2014 | 54 | 0.120 |
Why?
|
| Stomatitis | 1 | 2013 | 8 | 0.120 |
Why?
|
| ELAV Proteins | 1 | 2013 | 17 | 0.120 |
Why?
|
| Respiration | 1 | 2014 | 91 | 0.120 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2013 | 22 | 0.120 |
Why?
|
| Osteoblasts | 1 | 2014 | 99 | 0.120 |
Why?
|
| Proteins | 2 | 2011 | 473 | 0.120 |
Why?
|
| Gamma Rays | 1 | 2013 | 64 | 0.120 |
Why?
|
| Signal Transduction | 8 | 2017 | 2688 | 0.120 |
Why?
|
| Autophagy | 1 | 2016 | 207 | 0.120 |
Why?
|
| Stem Cells | 1 | 2015 | 248 | 0.120 |
Why?
|
| Protease Inhibitors | 1 | 2013 | 76 | 0.120 |
Why?
|
| Fibrosis | 1 | 2015 | 371 | 0.120 |
Why?
|
| Integrins | 3 | 2010 | 115 | 0.120 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2013 | 28 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 624 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2012 | 1692 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1745 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 56 | 0.110 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2012 | 15 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 25 | 0.110 |
Why?
|
| RNA Stability | 1 | 2013 | 55 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2017 | 617 | 0.110 |
Why?
|
| S100 Proteins | 1 | 2012 | 42 | 0.110 |
Why?
|
| Fibronectins | 1 | 2012 | 130 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2016 | 1341 | 0.110 |
Why?
|
| Cytokines | 1 | 2016 | 866 | 0.100 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 236 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1034 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2012 | 324 | 0.100 |
Why?
|
| Collagen | 2 | 2012 | 636 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2013 | 1199 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 215 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 2790 | 0.100 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2010 | 9 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2008 | 195 | 0.090 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 71 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 563 | 0.090 |
Why?
|
| Cell Survival | 2 | 2009 | 901 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1293 | 0.080 |
Why?
|
| Male | 6 | 2016 | 37281 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2008 | 86 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 189 | 0.080 |
Why?
|
| RAW 264.7 Cells | 2 | 2017 | 42 | 0.070 |
Why?
|
| Female | 3 | 2016 | 38015 | 0.070 |
Why?
|
| Humans | 8 | 2017 | 68525 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 284 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 807 | 0.060 |
Why?
|
| Focal Adhesions | 1 | 2003 | 25 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2013 | 111 | 0.060 |
Why?
|
| Endocytosis | 1 | 2003 | 113 | 0.060 |
Why?
|
| src-Family Kinases | 1 | 2003 | 91 | 0.060 |
Why?
|
| Heart Failure | 2 | 2010 | 1179 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 541 | 0.050 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2011 | 40 | 0.050 |
Why?
|
| Cell Line | 2 | 2014 | 1752 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2014 | 432 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 1849 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2013 | 1663 | 0.040 |
Why?
|
| Injections, Intravenous | 2 | 2009 | 215 | 0.040 |
Why?
|
| Nucleocapsid Proteins | 1 | 2017 | 8 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2017 | 64 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 209 | 0.040 |
Why?
|
| Angiotensins | 1 | 2016 | 16 | 0.040 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2016 | 11 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2016 | 61 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 63 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2015 | 13 | 0.030 |
Why?
|
| Nerve Regeneration | 1 | 2015 | 42 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 434 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 114 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 492 | 0.030 |
Why?
|
| Mind-Body Therapies | 1 | 2014 | 4 | 0.030 |
Why?
|
| Psychophysiology | 1 | 2014 | 11 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 765 | 0.030 |
Why?
|
| Time Factors | 3 | 2009 | 4655 | 0.030 |
Why?
|
| Basal Forebrain | 1 | 2014 | 15 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 78 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 140 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2014 | 113 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 710 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 2013 | 51 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 498 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2013 | 68 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2013 | 14 | 0.030 |
Why?
|
| bcl-Associated Death Protein | 1 | 2013 | 19 | 0.030 |
Why?
|
| CELF1 Protein | 1 | 2013 | 7 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 929 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 71 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 56 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 76 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 1032 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 614 | 0.030 |
Why?
|
| Macrophages | 1 | 2016 | 647 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 2550 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2011 | 104 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 252 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 87 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 47 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 508 | 0.020 |
Why?
|
| Gelsolin | 1 | 2008 | 6 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2008 | 51 | 0.020 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2008 | 24 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 756 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2008 | 36 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2009 | 133 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 83 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 160 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2009 | 383 | 0.020 |
Why?
|
| Histones | 1 | 2008 | 111 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 453 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2008 | 368 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 514 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 586 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2009 | 318 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 323 | 0.020 |
Why?
|
| Models, Biological | 1 | 2008 | 981 | 0.010 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2003 | 7 | 0.010 |
Why?
|
| Histidine | 1 | 2003 | 17 | 0.010 |
Why?
|
| Vinculin | 1 | 2003 | 15 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 27 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 2003 | 48 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2003 | 84 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 155 | 0.010 |
Why?
|
| Tyrosine | 1 | 2003 | 196 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 295 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 5300 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 337 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 7028 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 202 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 1027 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 21375 | 0.010 |
Why?
|